Validating chromatographic

Posted by / 16-Dec-2019 11:04

A properly designed system will provide a high degree of assurance that every step, process, and change has been properly evaluated before its implementation.

Testing a sample of a final product is not considered sufficient evidence that every product within a batch meets the required specification.

Qualification includes the following steps: There are instances when it is more expedient and efficient to transfer some tests or inspections from the IQ to the OQ, or from the OQ to the PQ.

This is allowed for in the regulations, provided that a clear and approved justification is documented in the Validation Plan (VP).

The Validation Master Plan is a document that describes how and when the validation program will be executed in a facility.

Even though it is not mandatory, it is the document that outlines the principles involved in the qualification of a facility, defines the areas and systems to be validated and provides a written program for achieving and maintaining a qualified facility with validated processes.

The desired results are established in terms of specifications for outcome of the process.

Qualification of systems and equipment is therefore a part of the process of validation.

FDA, or any other food and drugs regulatory agency around the globe not only ask for a product that meets its specification but also require a process, procedures, intermediate stages of inspections, and testing adopted during manufacturing are designed such that when they are adopted they produce consistently similar, reproducible, desired results which meet the quality standard of product being manufactured and complies the Regulatory and Security Aspects.The General Principles of Software Validation (FDA 2002) defines verification as "Software verification provides objective evidence that the design outputs of a particular phase of the software development life cycle meet all of the specified requirements for that phase." It also defines Validation as "Confirmation by examination and provision of objective evidence that software specifications conform to user needs and intended uses, and that the particular requirements implemented through software can be consistently fulfilled".The software validation guideline states: “The software development process should be sufficiently well planned, controlled, and documented to detect and correct unexpected results from software changes." Annex 11 states "The validation documentation and reports should cover the relevant steps of the life cycle." Weichel (2004) recently found that over twenty warning letters issued by the FDA to pharmaceutical companies specifically cited problems in Computer System Validation between 19.Validation is the process of establishing documentary evidence demonstrating that a procedure, process, or activity carried out in testing and then production maintains the desired level of compliance at all stages.In the pharmaceutical industry, it is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results.

validating chromatographic-45validating chromatographic-34validating chromatographic-83

In the UK, computer validation is covered in Annex 11 of the EU GMP regulations (EMEA 2011).